1. Current state of quality of life and patient-reported outcomes research;Bottomley;Eur J Cancer,2019
2. Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims clinical/medical guidance for industry patient-reported outcome measures: use in medical product development to support. 2009;43.
3. European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient-reported outcome (PRO) measures in oncology studies. 2016. 2016;18.
4. Unintended consequences of expensive cancer therapeutics—the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the john conley lecture;Fojo;JAMA Otolaryngol Neck Surg.,2014
5. The prevention and treatment of missing data in clinical trials;Little;N Engl J Med,2012